USC Blood and Marrow Transplant and Cell Therapy Program
Locations
Transplant Summary
Overview
The USC Blood and Marrow transplant and Cell Therapy program at USC provides comprehensive hematopoietic stem cell transplant and cell therapy services, including autologous and allogeneic blood and marrow transplants, CAR-T and Immune Effector Cell Therapy products, to patients with a variety of hematologic disorders (e.g., acute leukemia, myelodysplasia, lymphoma, bone marrow failure syndromes etc.), solid tumors and autoimmune disorders.This center has been performing allogeneic transplants since 2011 and has been an NMDP transplant center since March 2013.
Attending physicians
Adult - Preet Chaudhary, Tam Eric, Ann Mohrbacher, Zaw Myint, Karrune Woan, George YaghmourTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
We provide patients a list of hotels within proximity to USC that offer reduced rates with USC discount codes. These hotels offer kitchenette allowing patients to prepare their own meals.Patient survival information for this center
This center's actual 1-year survival results are above the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 149 patients.The actual 1-year survival of these patients is 88.5%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.5% and 85.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
276
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC45Cord blood0Total46Unrelated donorMarrow14PBSC50Cord blood0Total64Total allogeneicMarrow15PBSC95Cord blood0Total110AutologousMarrowBoth marrow & PBSC 166PBSC—Cord blood—Total166Total combinedMarrowBoth marrow & PBSC 276PBSC—Cord blood0Total276All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-442345-641865+5Total46Unrelated 0-18019-441345-643565+16Total64Autologous 0-18019-443545-649565+36Total166Total 0-18019-447145-6414865+57Total276Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
USC BMT Program
1441 Eastlake Avenue Los Angeles, CA 90033 Phone:323-865-0904 For more information about this program: https://cancer.keckmedicine.org/patients/cancer-programs/blood-diseases-center/ (Opens in a new tab)Overview
USC offers survivorship Program. The program is overseen by a Survivorship attending physician, Nurse Practitioner and support staff. It offers survivors ongoing support with the information, tools and support to maximize their physical health, emotional adjustment and overall well-being and helps cancer survivors deal with the long-term health effects of radiation, surgery, chemotherapy and cellular therapy. Survivors may be seen in the clinic any time following completion of cancer treatment.
Staff
Program Director:Preet M. Chaudhary, MDProgram Coordinator:Sosy Fincher, RNMedical Specialties in Program
Allergy/immunology, cardiology, dermatology, endocrinology, gastroenterology, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 1 year after transplant.
- Adults (over age 22)
- Will provide care to adult patients who underwent transplant as a child
- Does not accept patients who were transplanted at another hospital